guest ::
| Home > Publications database > Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort. > print |
| Home > Publications database > Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort. > print |
| 001 | 282669 | ||
| 005 | 20240229155044.0 | ||
| 024 | 7 | _ | |a 10.1002/mds.29602 |2 doi |
| 024 | 7 | _ | |a pmid:37675653 |2 pmid |
| 024 | 7 | _ | |a 0885-3185 |2 ISSN |
| 024 | 7 | _ | |a 1531-8257 |2 ISSN |
| 024 | 7 | _ | |a altmetric:153908669 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-01815 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Zhao, Yujia |0 0000-0002-5275-0036 |b 0 |
| 245 | _ | _ | |a Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort. |
| 260 | _ | _ | |a New York, NY |c 2023 |b Wiley |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1703227555_27741 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2023 Dec;38(12):2302-2307 |
| 520 | _ | _ | |a Metals have been postulated as environmental concerns in the etiology of Parkinson's disease (PD), but metal levels are typically measured after diagnosis, which might be subject to reverse causality.The aim of this study was to investigate the association between prediagnostic blood metal levels and PD risk.A case-control study was nested in a prospective European cohort, using erythrocyte samples collected before PD diagnosis.Most assessed metals were not associated with PD risk. Cadmium has a suggestive negative association with PD (odds ratio [95% confidence interval] for the highest quartile, 0.70 [0.42-1.17]), which diminished among never smokers. Among current smokers only, lead was associated with decreased PD risk (0.06 [0.01-0.35]), whereas arsenic showed associations toward an increased PD risk (1.85 [0.45-7.93]).We observe no strong evidence to support a role of metals in the development of PD. In particular, smoking may confound the association with tobacco-derived metals. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a Parkinson's disease |2 Other |
| 650 | _ | 7 | |a cohort study |2 Other |
| 650 | _ | 7 | |a metals |2 Other |
| 650 | _ | 7 | |a prospective exposure assessment |2 Other |
| 700 | 1 | _ | |a Ray, Anushree |b 1 |
| 700 | 1 | _ | |a Broberg, Karin |b 2 |
| 700 | 1 | _ | |a Kippler, Maria |b 3 |
| 700 | 1 | _ | |a Lill, Christina M |b 4 |
| 700 | 1 | _ | |a Vineis, Paolo |b 5 |
| 700 | 1 | _ | |a Katzke, Verena A |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 6 |u dkfz |
| 700 | 1 | _ | |a Rodriguez-Barranco, Miguel |b 7 |
| 700 | 1 | _ | |a Chirlaque, María-Dolores |b 8 |
| 700 | 1 | _ | |a Guevara, Marcela |b 9 |
| 700 | 1 | _ | |a Gómez, Jesús-Humberto |b 10 |
| 700 | 1 | _ | |a Hansen, Johnni |b 11 |
| 700 | 1 | _ | |a Panico, Salvatore |b 12 |
| 700 | 1 | _ | |a Middleton, Lefkos T |b 13 |
| 700 | 1 | _ | |a Masala, Giovanna |b 14 |
| 700 | 1 | _ | |a Pala, Valeria |b 15 |
| 700 | 1 | _ | |a Vinagre-Aragon, Ana |b 16 |
| 700 | 1 | _ | |a Zibetti, Maurizio |b 17 |
| 700 | 1 | _ | |a Vermeulen, Roel |b 18 |
| 700 | 1 | _ | |a Peters, Susan |0 0000-0001-5662-1971 |b 19 |
| 773 | _ | _ | |a 10.1002/mds.29602 |g p. mds.29602 |0 PERI:(DE-600)2041249-6 |n 12 |p 2302-2307 |t Movement disorders |v 38 |y 2023 |x 0885-3185 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:282669 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2022-11-11 |w ger |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-11 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-24 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b MOVEMENT DISORD : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-24 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-24 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b MOVEMENT DISORD : 2022 |d 2023-10-24 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|